PRECIGEN
Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
PRECIGEN
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
1998-01-01
Address:
Germantown, Maryland, United States
Country:
United States
Website Url:
http://www.precigen.com
Total Employee:
251+
Status:
Active
Contact:
15409610734
Email Addresses:
[email protected]
Total Funding:
525.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving IPv6 Typekit Microsoft AddThis
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2017-01-24 | GenVec | GenVec acquired by Precigen | N/A |
2016-02-25 | EnviroFlight | EnviroFlight acquired by Precigen | N/A |
2015-08-10 | Oxitec | Oxitec acquired by Precigen | 160 M USD |
2015-02-13 | ActoGeniX | ActoGeniX acquired by Precigen | 60 M USD |
2013-12-20 | Medistem | Medistem acquired by Precigen | N/A |
2011-10-24 | Immunologix | Immunologix acquired by Precigen | N/A |
2011-02-02 | Agarigen, Inc | Agarigen, Inc acquired by Precigen | N/A |
Investors List
Randal J. Kirk
Randal J. Kirk investment in Series F - Precigen
Third Security
Third Security investment in Series F - Precigen
Randal J. Kirk
Randal J. Kirk investment in Series E - Precigen
NewVa Capital Partners
NewVa Capital Partners investment in Series E - Precigen
Third Security
Third Security investment in Series E - Precigen
Third Security
Third Security investment in Series C - Precigen
NewVa Capital Partners
NewVa Capital Partners investment in Venture Round - Precigen
Third Security
Third Security investment in Series B - Precigen
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2014-12-02 | Histogenics | Precigen investment in Post-IPO Equity - Histogenics | 70 M USD |
Key Employee Changes
Date | New article |
---|---|
2021-10-12 | Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer |
Official Site Inspections
http://www.precigen.com Semrush global rank: 1.95 M Semrush visits lastest month: 11.04 K
- Host name: 174.60.185.35.bc.googleusercontent.com
- IP address: 35.185.60.174
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York